EUVIMEDEUVIMED entdecken
Crossref

Impact of portal‐phase signal intensity of dynamic gadoxetic acid‐enhanced magnetic resonance imaging in hepatocellular carcinoma

Takahiro Tomino, Shinji Itoh iD, Daisuke Okamoto, Shohei Yoshiya, Yoshihiro Nagao, Noboru Harada, Nobuhiro Fujita, Yasuhiro Ushijima, Kousei Ishigami, Tomoharu Yoshizumi iD

Journal of Hepato-Biliary-Pancreatic Sciences · 2023

DOI: 10.1002/jhbp.1345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2023. Verfasst von Takahiro Tomino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To evaluate the prognostic impact of dynamic gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (MRI) in patients with hepatocellular carcinoma (HCC).

Methods

We retrospectively reviewed the data of 206 patients with HCC who underwent preoperative Gd‐EOB‐DTPA‐enhanced MRI and hepatectomy and quantitatively evaluated the signal intensity ratio of the tumor to the surrounding liver tissue in the portal phase (SIRPP). We verified the survival rates and assessed the prognostic factors associated with overall survival (OS) and recurrence‐free survival (RFS) using SIRPP.

Results

Multivariate analysis revealed that the independent predictive factors for poorly‐differentiated HCC were α‐fetoprotein > 20 ng/mL (hazard ratio [HR]: 3.1909, 95% confidence interval [CI]: 1.3464–7.5622, p = .0084) and SIRPP ≤ 0.85 (HR: 3.7155, 95% CI: 1.521–9.076, p = .004). The 5‐year OS and RFS rates in the high and low SIRPP groups were 83.2 and 52.1%, respectively ( p < .0001) and 49.7 and 18.5%, respectively ( p = .0003). Multivariate analysis revealed that SIRPP ≤ 0.68 was an independent prognostic factor related to OS (HR: 4.4537, 95% CI: 1.6581–11.9626, p = .003).

Conclusion

The SIRPP of preoperative Gd‐EOB‐DTPA‐enhanced MRI might predict the histological differentiation and prognosis of HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansRetrospective StudiesContrast MediaGadolinium DTPAMagnetic Resonance Imaging

Stichwörter der Autor:innen

cell differentiationgadolinium DTPAhepatocellular carcinomamagnetic resonance imagingprognosis

Substanzen

gadolinium ethoxybenzyl DTPAContrast MediaGadolinium DTPA

Autor:innen und Institutionen

  • Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Departments of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

ORCID-Profile: Shinji Itoh, Tomoharu Yoshizumi

Zitieren

APA

Tomino, T., Itoh, S., Okamoto, D., Yoshiya, S., Nagao, Y., Harada, N., Fujita, N., Ushijima, Y., Ishigami, K., & Yoshizumi, T. (2023). Impact of portal‐phase signal intensity of dynamic gadoxetic acid‐enhanced magnetic resonance imaging in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1345

Vancouver

Tomino T, Itoh S, Okamoto D, Yoshiya S, Nagao Y, Harada N, et al. Impact of portal‐phase signal intensity of dynamic gadoxetic acid‐enhanced magnetic resonance imaging in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences. 2023. doi:10.1002/jhbp.1345

BibTeX
@article{Tomino2023,
  author = {Tomino, Takahiro and Itoh, Shinji and Okamoto, Daisuke and Yoshiya, Shohei and Nagao, Yoshihiro and Harada, Noboru and Fujita, Nobuhiro and Ushijima, Yasuhiro and Ishigami, Kousei and Yoshizumi, Tomoharu},
  title = {Impact of portal‐phase signal intensity of dynamic gadoxetic acid‐enhanced magnetic resonance imaging in hepatocellular carcinoma},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2023},
  doi = {10.1002/jhbp.1345}
}
Kostenlos starten →